Protocol Ledger

NCT06275958 · Phase III · RECRUITING

DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer

Interventional Phase III clinical trial protocol NCT06275958 sponsored by Leiden University Medical Center in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-07-01 Enrollment: 587 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06275958
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)587 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06275958
Protocol FieldVerified Registry Value
NCT IdentifierNCT06275958
Consolidated Lead SponsorLeiden University Medical Center
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment587 participants (ESTIMATED)
Registered Start Date2024-07-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06275958
Hospital Research SiteLocationSite Profile
Amsterdam UMCAmsterdam, NetherlandsOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI